elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37244781-65769E79-79DB-466E-B96C-2A52A8AE1CA9
Q37244781-65769E79-79DB-466E-B96C-2A52A8AE1CA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37244781-65769E79-79DB-466E-B96C-2A52A8AE1CA9
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.
P2860
Q37244781-65769E79-79DB-466E-B96C-2A52A8AE1CA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37244781-65769E79-79DB-466E-B96C-2A52A8AE1CA9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c8cc491965b12059ea188376c7926152a96c8122
P2860
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.